Earnings Ahead

AGLE - Aeglea BioTherapeutics, Inc.

0.375 -0.0038 -1

Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

About

Profile


Headquarters

Austin, Texas, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

AGLE



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Aeglea BioTherapeutics GAAP EPS of -$0.99 beats by $0.03, revenue of $2.33M beats by $0.1M
  • Aeglea BioTherapeutics names Jeffrey Goldberg as CEO; shares slide on corporate and clinical development strategy
  • Aeglea BioTherapeutics appoints Linda Neuman as chief medical officer
  • Aeglea Bio regains Nasdaq compliance
  • Aeglea BioTherapeutics upgraded to overweight at Wells Fargo on pegtarviliase optimism
  • Aeglea stock dips as FDA places partial hold on enrolling under 18 patients in metabolic disorder trial
  • Aeglea Bio announces departure of CEO, corporate restructuring
  • Aeglea stock jumps ~58% on EMA validation of marketing application for enzyme pegzilarginase
  • Aeglea BioTherapeutics GAAP EPS of -$0.27 beats by $0.04, revenue of $0.63M misses by $0.08M
  • Aeglea BioTherapeutics receives FDA Refuse to File letter for pegzilarginase
  • CRISPR, Xencor stock falls as Piper Sandler slashes price target in biotech space
  • Aeglea BioTherapeutics to raise $45M in stock and warrants offering
  • Aeglea BioTherapeutics GAAP EPS of -$0.37, revenue of $1.36B
  • Aeglea stock soars 24% on filing seeking FDA approval of pegzilarginase for rare disorder
  • Aeglea surges 40% following additional phase 3 data for pegzilarginase for rare disorder
  • Aeglea BioTherapeutics GAAP EPS of -$1.00 beats by $0.02, revenue of $18.73M beats by $1.33M
  • Aeglea director resigns after disagreement on financing plans
  • Aeglea BioTherapeutics slumps 5% on withdrawn offering
  • Aeglea BioTherapeutics announces proposed public offering
  • Aeglea says pivotal trial for pegzilarginase in Arginase 1 Deficiency met main goal
PEERS
/XLV

XLV

Date Price Open High Low Vol Change
Mar 26 37.73 40.03
40.67
37.57
261K -2.48%
Mar 25 38.69 41.2
42.08
37.99
429K -6.09%
Mar 22 41.2 41.37
42.43
39.62
302K 3.36%
Mar 21 39.86 40.12
42.78
38.53
397K 0.25%
Mar 20 39.76 38.29
40.33
37.41
314K 3.57%
 
Mar 19 38.39 39.9
41.02
37.63
957K -4.19%
Mar 18 40.07 47.89
47.97
39.59
475K -11.68%
Mar 15 45.37 41.41
47.61
41
2.2M 8.23%
Mar 14 41.92 44.51
44.74
41.04
386K -5.82%
Mar 13 44.51 42.55
45.82
42.55
295K 5.17%
Mar 12 42.32 41.24
42.45
39.39
177K 3.50%
Mar 11 40.89 37.06
41.69
35.93
507K 7.80%
Mar 8 37.93 39.74
41.01
37.38
382K -2.37%
Mar 7 38.85 40.37
41.09
38.05
552K -3.5%
Mar 6 40.26 37.75
40.81
36.15
870K 6.93%
Mar 5 37.65 36.99
39.77
36.29
1.8M 7.66%
Mar 4 34.97 31.39
35.35
30.9
1.3M 16.96%
Mar 1 29.9 30.18
32.99
28.48
1.0M 8.97%
Feb 29 27.44 26.45
28.8
24.85
1.2M 5.13%
Feb 28 26.1 24.75
26.32
24.35
383K 4.78%
Feb 27 24.91 24.25
24.91
23.62
763K 3.79%
Feb 26 24 23.58
24.77
23.05
970K 1.78%
Feb 23 23.58 20.96
23.74
20.13
747K 15.53%
Feb 22 20.41 20.56
21.19
20.07
207K -0.34%
Feb 21 20.48 21.91
21.91
20.12
225K -6.7%
Feb 20 21.95 23.37
23.37
21.39
296K -5.47%
Feb 16 23.22 23.02
23.75
22.43
997K 2.93%
Feb 15 22.56 22.64
22.96
22.16
236K 0.09%
Feb 14 22.54 22.5
23.34
22.39
276K 0.31%
Feb 13 22.47 22.34
23.21
21.73
409K -0.31%
Feb 12 22.54 23.67
24
22.06
528K -5.89%
Feb 9 23.95 24.02
24.58
23.56
766K 1.10%
Feb 8 23.69 24.1
24.58
23.64
193K -1.29%
Feb 7 24 25.53
26.04
23.77
238K -5.99%
Feb 6 25.53 25.31
26.08
25.25
178K 0.87%
Feb 5 25.31 25.64
25.64
24.48
498K -1.67%
Feb 2 25.74 25.63
26.1
24.56
314K -0.46%
Feb 1 25.86 25.93
26.45
25.18
181K -0.19%
Jan 31 25.91 27.85
28.28
25.84
551K -6.12%
Jan 30 27.6 26.71
28.09
26.6
411K -0.29%
Jan 29 27.68 27.5
28.59
26.82
117K 0.65%
Jan 26 27.5 27.41
28
26.74
191K 1.85%
Jan 25 27 26.92
27.92
26.38
327K 0.37%
Jan 24 26.9 27.6
28.5
26.72
168K -1.75%
Jan 23 27.38 27.13
28.66
26.63
152K 0.92%
Jan 22 27.13 24.31
27.25
24.22
557K 12.48%
Jan 19 24.12 21.78
24.81
21.55
408K 10.74%
Jan 18 21.78 21.54
21.96
21.08
106K 1.02%
Jan 17 21.56 21.6
22.43
20.5
228K -1.1%
Jan 16 21.8 21.45
22.42
21.06
265K 1.87%
Jan 12 21.4 22.43
23.37
20.87
593K 1.95%
Jan 11 20.99 21.8
22.02
20.32
321K -5.15%
Jan 10 22.13 23.5
24.75
21.94
168K -5.27%
Jan 9 23.36 24.62
25
22.34
654K -6.18%
Jan 8 24.9 22.17
25.81
21.4
665K 11.96%
Jan 5 22.24 22.17
22.86
21.02
116K -1.33%
Jan 4 22.54 21.07
23
20.11
145K 7.33%
Jan 3 21 21.55
22.08
18.54
98.6K -1.87%
Jan 2 21.4 21.99
22.1
19.59
93.9K -0.56%
Dec 29, 2023 21.52 20.5
22
19.83
111K 0%